[Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
D000368:Aged; D002219:Carbamates; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications / Q000188:drug therapy*; D008297:Male; D005222:Mental Fatigue / Q000188:drug therapy; D008875:Middle Aged; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014717:Vertigo / Q000188:drug therapy
D002219:Carbamates; D011726:Pyridinium Compounds
Efeitos do piridinolcarbamato na arteriosclerose cerebral crônica.